Home › Stomach Cancer › Florida › Deltona
Stomach Cancer clinical trials in Deltona, FL
3 studies for Stomach Cancer are looking for participants at sites in and around Deltona (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
RecruitingPhase 2/3
- Florida Cancer Specialists, Daytona Beach · 26 mi away
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi away
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Florida Hospital FISH, Orange City · 4 mi away
- Florida Hospital DeLand, DeLand · 9 mi away
- Florida Hospital Memorial Medical Center, Daytona Beach · 26 mi away
About Stomach Cancer
Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.
More about Stomach Cancer on MedlinePlus
Stomach Cancer trials in other cities
- Houston, TX42 studies
- Boston, MA32 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Baldwin Park, CA22 studies
- Los Angeles, CA22 studies
- Arlington, VA20 studies
- Dallas, TX19 studies
- San Antonio, TX19 studies
- Grand Rapids, MI18 studies
- St. Louis, MO18 studies
- Chicago, IL16 studies
Other studies in Deltona
- Non-Small Cell Lung Cancer15 studies
- Obesity11 studies
- Alzheimer's Disease10 studies
- Type 2 Diabetes10 studies
- Overweight9 studies
- Breast Cancer8 studies
- Lung Cancer8 studies
- Cancer (all types)7 studies
- Metastatic Cancer5 studies
- COPD5 studies
- High Blood Pressure5 studies
- Melanoma5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.